CDC and FDA response to risk of confusion in dosing Tamiflu oral suspension.
Daniel S
DS
Budnitz
Linda L
LL
Lewis
Nadine
N
Shehab
Debra
D
Birnkrant
D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage*; D002487:Centers for Disease Control and Prevention, U.S.; D054796:Drug Dosage Calculations; D004348:Drug Labeling / Q000592:standards*; D006801:Humans; D008508:Medication Errors / Q000517:prevention & control*; D053139:Oseltamivir / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D053139:Oseltamivir